List of structures (as of 09/2025)
6AL5 - CD19 (N138Q) in complex with Fab of mAb B43
3PP4 - CD20 in complex with obinutuzumab
5VL3 - CD22 d1-d3 in complex with Fab of Epratuzumab
5TL5 - CD27 in complex with M2177 mAb
5TLJ - CD27 in complex with M2177 mAb and M2191 mAb (Includes data at 298K)
1YJD - CD28 in complex with 5.11A1 mAb
4CMH - CD38 in complex with SAR650984 mAb
1I9R - CD40L in complex with 5C8 mAb
7D4B - CD137 (4-1BB) in complex with a vHH (llama single-domain antibody)
4OD2 - DR5 in complex with Fab of apomab
4ZQK - PD-1 in complex with ligand PD-L1
6UMT - PD-1 in complex with ligand PD-L2 (Includes binding free energy calculations)
7E9B - PD-1 in complex with HLX10 mAb
6J14 - PD-1 in complex with GY-14 mAb
7WSL - PD-1 in complex with dostarlimab
5GRJ - PD-L1 in complex with avelumab (Includes data at 298K)
5GGT - PD-L1 in complex with Fab of BMS-936559 mAb
5X8L - PD-L1 in complex with atezolizumab
5XJ4 - PD-L1 in complex with durvalumab-scFv
7DV4 - CTLA-4 in complex with VH domain of 4003-1 mAb (Includes binding free energy calculations)
5GGV - CTLA-4 in complex with tremelimumab Fab
6RP8 - CTLA-4 in complex with ipilimumab Fab
1S78 - ErbB2 (HER2) in complex with pertuzumab
1YY9 - ERB2 (HER2) in complex with Fab of cetuximab/Erbitux
5DK3 - Pembrolizumab (Keytruda), IgG4 S228P, anti-PD-1 antibody (Includes data at 298K)
5X8M - Durvalumab (Imfinzi), anti-PD-L1 antibody (Includes data at 298K)
5GGR - PD-1 in complex with nivolumab Fab (Includes data at 298K)
5GGS - PD-1 in complex with pembrolizumab Fab (Includes data at 298K)